Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence - a systematic review and meta-analysis.

CONCLUSION: Regarding the use of gene expression assays in breast cancer, evidence on patient effects, informing patient-level chemotherapy decision making, is available. However, evidence for prioritisation at the overall health care level, i.e. use of, versus no use of, such assays, is largely lacking.
PMID: 32504183 [PubMed - as supplied by publisher]

Source: Clinical Genitourinary Cancer - June 4, 2020 Category: Cancer & Oncology Authors: Wallerstedt SM, Nilsson Ek A, Olofsson Bagge R, Kovács A, Strandell A, Linderholm B Tags: Eur J Clin Pharmacol Source Type: research